Organism |
Feature Type |
Feature ID |
Info |
Relationship |
Display |
Orthologous Group |
Coexpression Group |
Vitis vinifera |
polypeptide |
GSVIVT01003976001.Genoscope12X
|
GSVIVT01003976001 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 9) |
OG0000506 |
|
Vitis vinifera |
polypeptide |
GSVIVT01004747001.Genoscope12X
|
GSVIVT01004747001 |
mRNA
|
K13456 - RPM1-interacting protein 4 (RIN4) (1 of 3) |
OG0000506 |
|
Vitis vinifera |
polypeptide |
GSVIVT01007562001.Genoscope12X
|
GSVIVT01007562001 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 9) |
OG0000506 |
|
Vitis vinifera |
polypeptide |
GSVIVT01014701001.Genoscope12X
|
GSVIVT01014701001 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 9) |
OG0000506 |
|
Vitis vinifera |
polypeptide |
GSVIVT01020994001.Genoscope12X
|
GSVIVT01020994001 |
mRNA
|
K13456 - RPM1-interacting protein 4 (RIN4) (1 of 3) |
OG0000506 |
|
Vitis vinifera |
polypeptide |
GSVIVT01030113001.Genoscope12X
|
GSVIVT01030113001 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 9) |
OG0000506 |
|
Glycine max |
polypeptide |
Glyma.02G301100.1.Wm82.a2.v1
|
Glyma.02G301100.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 25) |
OG0000506 |
|
Glycine max |
polypeptide |
Glyma.02G308200.1.Wm82.a2.v1
|
Glyma.02G308200.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 25) |
OG0000506 |
|
Glycine max |
polypeptide |
Glyma.03G084000.1.Wm82.a2.v1
|
Glyma.03G084000.1 |
mRNA
|
K13456 - RPM1-interacting protein 4 (RIN4) (1 of 5) |
OG0000506 |
|
Glycine max |
polypeptide |
Glyma.05G044400.1.Wm82.a2.v1
|
Glyma.05G044400.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 25) |
OG0000506 |
|
Glycine max |
polypeptide |
Glyma.06G248300.1.Wm82.a2.v1
|
Glyma.06G248300.1 |
mRNA
|
PTHR33159:SF3 - RPM1-INTERACTING PROTEIN 4-LIKE PROTEIN (1 of 4) |
OG0000506 |
|
Glycine max |
polypeptide |
Glyma.08G330400.1.Wm82.a2.v1
|
Glyma.08G330400.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 25) |
OG0000506 |
|
Glycine max |
polypeptide |
Glyma.08G349500.1.Wm82.a2.v1
|
Glyma.08G349500.1 |
mRNA
|
K13456 - RPM1-interacting protein 4 (RIN4) (1 of 5) |
OG0000506 |
|
Glycine max |
polypeptide |
Glyma.08G349500.2.Wm82.a2.v1
|
Glyma.08G349500.2 |
mRNA
|
|
OG0000506 |
|
Glycine max |
polypeptide |
Glyma.08G349500.3.Wm82.a2.v1
|
Glyma.08G349500.3 |
mRNA
|
|
OG0000506 |
|
Glycine max |
polypeptide |
Glyma.10G110600.1.Wm82.a2.v1
|
Glyma.10G110600.1 |
mRNA
|
PTHR33159:SF3 - RPM1-INTERACTING PROTEIN 4-LIKE PROTEIN (1 of 4) |
OG0000506 |
|
Glycine max |
polypeptide |
Glyma.11G245900.1.Wm82.a2.v1
|
Glyma.11G245900.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 25) |
OG0000506 |
|
Glycine max |
polypeptide |
Glyma.12G102200.1.Wm82.a2.v1
|
Glyma.12G102200.1 |
mRNA
|
PTHR33159:SF3 - RPM1-INTERACTING PROTEIN 4-LIKE PROTEIN (1 of 4) |
OG0000506 |
|
Glycine max |
polypeptide |
Glyma.14G013000.1.Wm82.a2.v1
|
Glyma.14G013000.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 25) |
OG0000506 |
|
Glycine max |
polypeptide |
Glyma.16G090700.1.Wm82.a2.v1
|
Glyma.16G090700.1 |
mRNA
|
K13456 - RPM1-interacting protein 4 (RIN4) (1 of 5) |
OG0000506 |
|
Glycine max |
polypeptide |
Glyma.17G126900.1.Wm82.a2.v1
|
Glyma.17G126900.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 25) |
OG0000506 |
|
Glycine max |
polypeptide |
Glyma.17G126900.2.Wm82.a2.v1
|
Glyma.17G126900.2 |
mRNA
|
|
OG0000506 |
|
Glycine max |
polypeptide |
Glyma.17G184500.1.Wm82.a2.v1
|
Glyma.17G184500.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 25) |
OG0000506 |
|
Glycine max |
polypeptide |
Glyma.17G193000.1.Wm82.a2.v1
|
Glyma.17G193000.1 |
mRNA
|
PTHR33159:SF3 - RPM1-INTERACTING PROTEIN 4-LIKE PROTEIN (1 of 4) |
OG0000506 |
|
Glycine max |
polypeptide |
Glyma.17G193500.1.Wm82.a2.v1
|
Glyma.17G193500.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 25) |
OG0000506 |
|
Glycine max |
polypeptide |
Glyma.18G011300.1.Wm82.a2.v1
|
Glyma.18G011300.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 25) |
OG0000506 |
|
Glycine max |
polypeptide |
Glyma.18G011300.2.Wm82.a2.v1
|
Glyma.18G011300.2 |
mRNA
|
|
OG0000506 |
|
Glycine max |
polypeptide |
Glyma.18G075900.1.Wm82.a2.v1
|
Glyma.18G075900.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 25) |
OG0000506 |
|
Glycine max |
polypeptide |
Glyma.18G166800.1.Wm82.a2.v1
|
Glyma.18G166800.1 |
mRNA
|
K13456 - RPM1-interacting protein 4 (RIN4) (1 of 5) |
OG0000506 |
|
Gossypium raimondii |
polypeptide |
Gorai.001G232400.1.v2.1
|
Gorai.001G232400.1 |
mRNA
|
K13456 - RPM1-interacting protein 4 (RIN4) (1 of 2) |
OG0000506 |
|
Gossypium raimondii |
polypeptide |
Gorai.002G101100.1.v2.1
|
Gorai.002G101100.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 17) |
OG0000506 |
|
Gossypium raimondii |
polypeptide |
Gorai.002G101100.2.v2.1
|
Gorai.002G101100.2 |
mRNA
|
|
OG0000506 |
|
Gossypium raimondii |
polypeptide |
Gorai.003G003800.1.v2.1
|
Gorai.003G003800.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 17) |
OG0000506 |
|
Gossypium raimondii |
polypeptide |
Gorai.004G226600.1.v2.1
|
Gorai.004G226600.1 |
mRNA
|
K13456 - RPM1-interacting protein 4 (RIN4) (1 of 2) |
OG0000506 |
|
Gossypium raimondii |
polypeptide |
Gorai.004G226600.2.v2.1
|
Gorai.004G226600.2 |
mRNA
|
|
OG0000506 |
|
Gossypium raimondii |
polypeptide |
Gorai.004G226600.3.v2.1
|
Gorai.004G226600.3 |
mRNA
|
|
OG0000506 |
|
Gossypium raimondii |
polypeptide |
Gorai.005G173700.1.v2.1
|
Gorai.005G173700.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 17) |
OG0000506 |
|
Gossypium raimondii |
polypeptide |
Gorai.005G173700.2.v2.1
|
Gorai.005G173700.2 |
mRNA
|
|
OG0000506 |
|
Gossypium raimondii |
polypeptide |
Gorai.006G270200.1.v2.1
|
Gorai.006G270200.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 17) |
OG0000506 |
|
Gossypium raimondii |
polypeptide |
Gorai.007G165500.1.v2.1
|
Gorai.007G165500.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 17) |
OG0000506 |
|
Gossypium raimondii |
polypeptide |
Gorai.007G310200.1.v2.1
|
Gorai.007G310200.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 17) |
OG0000506 |
|
Gossypium raimondii |
polypeptide |
Gorai.008G204500.1.v2.1
|
Gorai.008G204500.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 17) |
OG0000506 |
|
Gossypium raimondii |
polypeptide |
Gorai.008G204500.2.v2.1
|
Gorai.008G204500.2 |
mRNA
|
|
OG0000506 |
|
Gossypium raimondii |
polypeptide |
Gorai.008G204500.3.v2.1
|
Gorai.008G204500.3 |
mRNA
|
|
OG0000506 |
|
Gossypium raimondii |
polypeptide |
Gorai.009G451800.1.v2.1
|
Gorai.009G451800.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 17) |
OG0000506 |
|
Gossypium raimondii |
polypeptide |
Gorai.009G451800.2.v2.1
|
Gorai.009G451800.2 |
mRNA
|
|
OG0000506 |
|
Gossypium raimondii |
polypeptide |
Gorai.010G250900.1.v2.1
|
Gorai.010G250900.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 17) |
OG0000506 |
|
Gossypium raimondii |
polypeptide |
Gorai.013G151900.1.v2.1
|
Gorai.013G151900.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 17) |
OG0000506 |
|
Boea hygrometrica |
polypeptide |
KZV16334.1
|
|
mRNA
|
hypothetical protein |
OG0000506 |
|
Boea hygrometrica |
polypeptide |
KZV17686.1
|
|
mRNA
|
hypothetical protein |
OG0000506 |
|
Boea hygrometrica |
polypeptide |
KZV25708.1
|
|
mRNA
|
hypothetical protein |
OG0000506 |
|
Boea hygrometrica |
polypeptide |
KZV36214.1
|
|
mRNA
|
hypothetical protein |
OG0000506 |
|
Boea hygrometrica |
polypeptide |
KZV56352.1
|
|
mRNA
|
hypothetical protein |
OG0000506 |
|
Boea hygrometrica |
polypeptide |
KZV57458.1
|
|
mRNA
|
hypothetical protein |
OG0000506 |
|
Kalanchoe fedtschenkoi |
polypeptide |
Kaladp0008s0298.1.v1.1
|
Kaladp0008s0298.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 12) |
OG0000506 |
|
Kalanchoe fedtschenkoi |
polypeptide |
Kaladp0033s0308.1.v1.1
|
Kaladp0033s0308.1 |
mRNA
|
PTHR33159:SF3 - RPM1-INTERACTING PROTEIN 4-LIKE PROTEIN (1 of 1) |
OG0000506 |
|
Kalanchoe fedtschenkoi |
polypeptide |
Kaladp0033s0308.2.v1.1
|
Kaladp0033s0308.2 |
mRNA
|
|
OG0000506 |
|
Kalanchoe fedtschenkoi |
polypeptide |
Kaladp0045s0096.1.v1.1
|
Kaladp0045s0096.1 |
mRNA
|
K13456 - RPM1-interacting protein 4 (RIN4) (1 of 3) |
OG0000506 |
|
Kalanchoe fedtschenkoi |
polypeptide |
Kaladp0051s0024.1.v1.1
|
Kaladp0051s0024.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 12) |
OG0000506 |
|
Kalanchoe fedtschenkoi |
polypeptide |
Kaladp0053s0563.1.v1.1
|
Kaladp0053s0563.1 |
mRNA
|
K13456 - RPM1-interacting protein 4 (RIN4) (1 of 3) |
OG0000506 |
|
Kalanchoe fedtschenkoi |
polypeptide |
Kaladp0068s0037.1.v1.1
|
Kaladp0068s0037.1 |
mRNA
|
PTHR33159:SF6 - RPM1-INTERACTING PROTEIN 4 (1 of 2) |
OG0000506 |
|
Kalanchoe fedtschenkoi |
polypeptide |
Kaladp0076s0144.1.v1.1
|
Kaladp0076s0144.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 12) |
OG0000506 |
|
Kalanchoe fedtschenkoi |
polypeptide |
Kaladp0088s0094.1.v1.1
|
Kaladp0088s0094.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 12) |
OG0000506 |
|
Kalanchoe fedtschenkoi |
polypeptide |
Kaladp0674s0025.1.v1.1
|
Kaladp0674s0025.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 12) |
OG0000506 |
|
Kalanchoe fedtschenkoi |
polypeptide |
Kaladp0674s0025.2.v1.1
|
Kaladp0674s0025.2 |
mRNA
|
|
OG0000506 |
|
Kalanchoe fedtschenkoi |
polypeptide |
Kaladp0867s0040.1.v1.1
|
Kaladp0867s0040.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 12) |
OG0000506 |
|
Kalanchoe fedtschenkoi |
polypeptide |
Kaladp0867s0040.2.v1.1
|
Kaladp0867s0040.2 |
mRNA
|
|
OG0000506 |
|
Kalanchoe laxiflora |
polypeptide |
Kalax.0012s0144.1.v1.1
|
Kalax.0012s0144.1 |
mRNA
|
K13456 - RPM1-interacting protein 4 (RIN4) (1 of 5) |
OG0000506 |
|
Kalanchoe laxiflora |
polypeptide |
Kalax.0040s0121.1.v1.1
|
Kalax.0040s0121.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 22) |
OG0000506 |
|
Kalanchoe laxiflora |
polypeptide |
Kalax.0040s0121.2.v1.1
|
Kalax.0040s0121.2 |
mRNA
|
|
OG0000506 |
|
Kalanchoe laxiflora |
polypeptide |
Kalax.0045s0107.1.v1.1
|
Kalax.0045s0107.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 22) |
OG0000506 |
|
Kalanchoe laxiflora |
polypeptide |
Kalax.0045s0107.2.v1.1
|
Kalax.0045s0107.2 |
mRNA
|
|
OG0000506 |
|
Kalanchoe laxiflora |
polypeptide |
Kalax.0046s0095.1.v1.1
|
Kalax.0046s0095.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 22) |
OG0000506 |
|
Kalanchoe laxiflora |
polypeptide |
Kalax.0054s0012.1.v1.1
|
Kalax.0054s0012.1 |
mRNA
|
PTHR33159:SF6 - RPM1-INTERACTING PROTEIN 4 (1 of 4) |
OG0000506 |
|
Kalanchoe laxiflora |
polypeptide |
Kalax.0065s0046.1.v1.1
|
Kalax.0065s0046.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 22) |
OG0000506 |
|
Kalanchoe laxiflora |
polypeptide |
Kalax.0078s0033.1.v1.1
|
Kalax.0078s0033.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 22) |
OG0000506 |
|
Kalanchoe laxiflora |
polypeptide |
Kalax.0108s0048.1.v1.1
|
Kalax.0108s0048.1 |
mRNA
|
K13456 - RPM1-interacting protein 4 (RIN4) (1 of 5) |
OG0000506 |
|
Kalanchoe laxiflora |
polypeptide |
Kalax.0308s0020.1.v1.1
|
Kalax.0308s0020.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 22) |
OG0000506 |
|
Kalanchoe laxiflora |
polypeptide |
Kalax.0356s0039.1.v1.1
|
Kalax.0356s0039.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 22) |
OG0000506 |
|
Kalanchoe laxiflora |
polypeptide |
Kalax.0503s0004.1.v1.1
|
Kalax.0503s0004.1 |
mRNA
|
K13456 - RPM1-interacting protein 4 (RIN4) (1 of 5) |
OG0000506 |
|
Kalanchoe laxiflora |
polypeptide |
Kalax.0513s0020.1.v1.1
|
Kalax.0513s0020.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 22) |
OG0000506 |
|
Kalanchoe laxiflora |
polypeptide |
Kalax.0632s0020.1.v1.1
|
Kalax.0632s0020.1 |
mRNA
|
K13456 - RPM1-interacting protein 4 (RIN4) (1 of 5) |
OG0000506 |
|
Kalanchoe laxiflora |
polypeptide |
Kalax.0633s0012.1.v1.1
|
Kalax.0633s0012.1 |
mRNA
|
PTHR33159:SF3 - RPM1-INTERACTING PROTEIN 4-LIKE PROTEIN (1 of 2) |
OG0000506 |
|
Kalanchoe laxiflora |
polypeptide |
Kalax.0633s0012.2.v1.1
|
Kalax.0633s0012.2 |
mRNA
|
|
OG0000506 |
|
Kalanchoe laxiflora |
polypeptide |
Kalax.0706s0003.1.v1.1
|
Kalax.0706s0003.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 22) |
OG0000506 |
|
Kalanchoe laxiflora |
polypeptide |
Kalax.0832s0001.1.v1.1
|
Kalax.0832s0001.1 |
mRNA
|
PTHR33159:SF3 - RPM1-INTERACTING PROTEIN 4-LIKE PROTEIN (1 of 2) |
OG0000506 |
|
Kalanchoe laxiflora |
polypeptide |
Kalax.1373s0002.1.v1.1
|
Kalax.1373s0002.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 22) |
OG0000506 |
|
Kalanchoe laxiflora |
polypeptide |
Kalax.1440s0002.1.v1.1
|
Kalax.1440s0002.1 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 22) |
OG0000506 |
|
Oryza sativa |
polypeptide |
LOC_Os02g49340.1.MSUv7.0
|
LOC_Os02g49340.1 |
mRNA
|
nitrate-induced NOI protein, putative, expressed |
OG0000506 |
|
Oryza sativa |
polypeptide |
LOC_Os03g63140.1.MSUv7.0
|
LOC_Os03g63140.1 |
mRNA
|
nitrate-induced NOI protein, expressed |
OG0000506 |
|
Oryza sativa |
polypeptide |
LOC_Os03g63140.2.MSUv7.0
|
LOC_Os03g63140.2 |
mRNA
|
nitrate-induced NOI protein, expressed |
OG0000506 |
|
Oryza sativa |
polypeptide |
LOC_Os03g63160.1.MSUv7.0
|
LOC_Os03g63160.1 |
mRNA
|
expressed protein |
OG0000506 |
|
Oryza sativa |
polypeptide |
LOC_Os04g52950.1.MSUv7.0
|
LOC_Os04g52950.1 |
mRNA
|
nitrate-induced NOI protein, expressed |
OG0000506 |
|
Oryza sativa |
polypeptide |
LOC_Os06g17870.1.MSUv7.0
|
LOC_Os06g17870.1 |
mRNA
|
nitrate-induced NOI protein, putative, expressed |
OG0000506 |
|
Oryza sativa |
polypeptide |
LOC_Os08g41470.2.MSUv7.0
|
LOC_Os08g41470.2 |
mRNA
|
proteophosphoglycan ppg4, putative, expressed |
OG0000506 |
|
Oryza sativa |
polypeptide |
LOC_Os09g07920.1.MSUv7.0
|
LOC_Os09g07920.1 |
mRNA
|
NOI protein, nitrate-induced, putative, expressed |
OG0000506 |
|
Linum usitatissimum |
polypeptide |
Lus10006250.BGIv1.0
|
Lus10006250 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 15) |
OG0000506 |
|
Linum usitatissimum |
polypeptide |
Lus10006361.BGIv1.0
|
Lus10006361 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 15) |
OG0000506 |
|
Linum usitatissimum |
polypeptide |
Lus10006451.BGIv1.0
|
Lus10006451 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 15) |
OG0000506 |
|
Linum usitatissimum |
polypeptide |
Lus10012316.BGIv1.0
|
Lus10012316 |
mRNA
|
PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 15) |
OG0000506 |
|